us en false false Default
Skip directly to Accessibility Notice
PPH VanEck Pharmaceutical ETF Please read important disclosure Close important disclosure false

PPH
VanEck Pharmaceutical ETF

PPH
VanEck Pharmaceutical ETF

  • NAV
    $101.53

    as of December 16, 2025
  • YTD RETURNS
    19.67%

    as of December 16, 2025
  • Total Net Assets
    $1.21B

    as of December 16, 2025
  • Total Expense Ratio
    0.36%
  • Inception Date
    12/20/2011

About PPH

VanEck Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

Buy Now
Let's Connect
Subscribe

Overview

Why PPH

  • Highly Liquid Companies: Tracks the largest most liquid pharmaceutical companies
  • Industry Leaders: Favors established industry leaders with meaningful scale
  • Global Scope: Provides exposure to U.S. and international equities for global industry representation  

Performance

Performance History:

Average Annual Total Returns* (%)

View All ETFs View All Indices
  1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 10.84 15.85 20.88 16.29 12.21 11.62 6.75 9.99
PPH (Share Price) 10.77 15.82 20.88 16.26 12.25 11.62 6.73 10.07
MVPPHTR (Index) 10.83 15.87 20.50 15.80 11.73 11.23 6.52 9.80
Performance Differential (NAV - Index) 0.01 -0.02 0.38 0.49 0.48 0.39 0.23 0.19
  1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 1.63 3.39 6.05 -2.88 12.60 9.85 5.68 9.08
PPH (Share Price) 1.67 3.44 6.11 -2.77 12.61 9.82 5.68 9.16
MVPPHTR (Index) 1.65 3.37 5.71 -3.33 12.10 9.46 5.45 8.89
Performance Differential (NAV - Index) -0.02 0.02 0.34 0.45 0.50 0.39 0.23 0.19

*Returns less than one year are not annualized.

The performance data quoted represents past performance. Past performance is not a guarantee of future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Performance may be lower or higher than performance data quoted. Please call 800.826.2333 or visit vaneck.com for performance current to the most recent month ended.

Prices as of 12/16/2025

NAV/
Market
Price 		Volume
30-Day Avg./
Last Trading Day 		Daily Change
NAV/
Last Price 		YTD Change NAV/
Last Price 		Premium/
Discount 		30-Day
Median
Bid Ask
Spread 		NAV
Chart
PPH $101.53
$101.52 		422,804
927,492 		$-1.11 / -1.08%
$-1.12 / -1.09% 		+19.67%
+19.72% 		$-0.01
-0.01% 		0.02%

Fees

Holdings

Daily Holdings (%) as of 12/16/2025

Download XLS Get holdings
Total Holdings: 26
Ticker
 Holding Name % of Net
Assets
Identifier (FIGI)
Shares
 Asset Class Market Value
(US$) 		Notional Value
LLY US
 Eli Lilly & Co 24.41
BBG000BNBDC2
266,520
 Stock 280,989,371 --
NVS US
 Novartis Ag 9.09
BBG000LYF3S8
774,524
 Stock 104,583,976 --
MRK US
 Merck & Co Inc 7.72
BBG000BPD168
904,740
 Stock 88,908,800 --
NVO US
 Novo Nordisk A/S 6.05
BBG000BQBKR3
1,422,713
 Stock 69,656,028 --
GSK US
 Gsk Plc 4.73
BBG000BLB481
1,117,294
 Stock 54,501,601 --
JNJ US
 Johnson & Johnson 4.68
BBG000BMHYD1
257,412
 Stock 53,876,332 --
PFE US
 Pfizer Inc 4.54
BBG000BR2B91
2,046,406
 Stock 52,244,745 --
BMY US
 Bristol-Myers Squibb Co 4.52
BBG000DQLV23
959,788
 Stock 52,049,303 --
MCK US
 Mckesson Corp 4.51
BBG000DYGNW7
64,108
 Stock 51,924,916 --
AZN US
 Astrazeneca Plc 4.44
BBG000BZ0DK8
559,976
 Stock 51,153,808 --
ABBV US
 Abbvie Inc 4.15
BBG0025Y4RY4
213,830
 Stock 47,827,356 --
SNY US
 Sanofi Sa/France 3.95
BBG000BBD5N1
959,574
 Stock 45,522,191 --
COR US
 Cencora Inc 3.58
BBG000MDCQC2
120,473
 Stock 41,168,034 --
ZTS US
 Zoetis Inc 3.24
BBG0039320N9
302,816
 Stock 37,316,016 --
HLN US
 Haleon Plc 2.83
BBG018GZNCH6
3,308,793
 Stock 32,591,611 --
TEVA US
 Teva Pharmaceutical Industries Ltd 2.34
BBG000C0CD58
895,916
 Stock 26,967,072 --
TAK US
 Takeda Pharmaceutical Co Ltd 2.29
BBG000LF8708
1,817,633
 Stock 26,410,207 --
JAZZ US
 Jazz Pharmaceuticals Plc 0.61
BBG000G9CGL0
41,289
 Stock 7,007,982 --
VTRS US
 Viatris Inc 0.60
BBG00Y4RQNH4
607,195
 Stock 6,958,455 --
ELAN US
 Elanco Animal Health Inc 0.43
BBG00LJYS1P8
221,189
 Stock 4,974,541 --
CORT US
 Corcept Therapeutics Inc 0.36
BBG000BKJG33
51,315
 Stock 4,162,673 --
AXSM US
 Axsome Therapeutics Inc 0.34
BBG00B6G7GL7
26,811
 Stock 3,937,732 --
BHC US
 Bausch Health Cos Inc 0.13
BBG000DLFM21
208,346
 Stock 1,443,838 --
OGN US
 Organon & Co 0.10
BBG00ZQRGW24
165,989
 Stock 1,156,943 --
PRGO US
 Perrigo Co Plc 0.08
BBG000CNFQW6
68,213
 Stock 888,133 --
-USD CASH-
 0.08
--
937,198
 Cash Bal 937,198 --
--
Other/Cash 0.17
--
0
 Cash 1,965,103 --
← Scroll for more information →
These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Portfolio

Sector Weightings (%) as at 11/30/2025

  • Sector

    % of Net Assets

  • Health Care

    99.84

  • Other/Cash

    0.16

Country Weightings (%) as at 11/30/2025

  • Country

    % of Net Assets

  • United States

    64.82

  • United Kingdom

    11.85

  • Switzerland

    8.69

  • Denmark

    6.04

  • France

    4.12

  • Japan

    2.25

  • Israel

    2.07

  • Other/Cash

    0.16

Distributions

Yields  as of  12/16/2025

Distribution Frequency

Quarterly

30-Day SEC Yield

1.84%

Distribution Yield

1.55%

12 Month Yield

1.91%

Yield information reflects temporary waivers of expenses and/or fees. Yields would have been reduced had these fees/expenses been included. In the absence of temporary expense waivers or reimbursements, the 30-Day SEC Yield for VanEck Pharmaceutical ETF would have been 1.84% on 12/16/25. Distributions may vary from time to time.

Team

Literature

PPH